Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  The Journal of Heart and Lung Transplantation

• Publication date

  1998-09-01

• Fields of study

  Medicine

• Identifiers
  PMID 9773859
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alloantibody responses in multiply transfused sickle cell patients.

  2008cited by this paper
• Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study.

  1995cited by this paper
• THE RELATIONSHIP AMONG DONOR‐RECIPIENT HLA MISMATCHES, REJECTION, AND DEATH FROM CORONARY ARTERY DISEASE IN CARDIAC TRANSPLANT RECIPIENTS1

  1994cited by this paper
• Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation.

  1991cited by this paper
• The role of anti-HLA antibodies in heart transplantation.

  1991cited by this paper
• Effects of recombinant human erythropoietin on HLA sensitization and cell mediated immunity.

  1990cited by this paper
• Prevention of HLA immunization with leukocyte-poor packed red cells and platelet concentrates obtained by filtration.

  1988cited by this paper
• Assessment of the risk for broad sensitization by blood transfusions.

  1984cited by this paper
• Transfusion therapy and HLA antibody response in patients undergoing open heart surgery

  1982cited by this paper

• Polyinosinic: polycytidylic acid induced inflammation enhances while lipopolysaccharide diminishes alloimmunity to platelet transfusion in mice

  2023cites this paper
• Cardiac Allograft Rejection: Strategies for Success in the Face of Immune Challenges.

  2023cites this paper
• How to Approach HLA Sensitization in Heart Transplant Candidates.

  2023cites this paper
• Enhanced alloresponse to platelet transfusion due to immune dysregulation following ablative chemotherapy in mice

  2023cites this paper
• HLA Sensitization in Patients Bridged to Lung Transplantation With Extracorporeal Membrane Oxygenation

  2023cites this paper
• Preoperative Evaluation and Care of Heart Transplant Candidates.

  2022cites this paper
• Elevated Plasma Immunoglobulin Levels Prior to Heart Transplantation Are Associated with Poor Post-Transplantation Survival

  2022cites this paper
• Detection and management of HLA sensitization in candidates for adult heart transplantation.

  2022cites this paper
• De Novo Human Leukocyte Antigen Allosensitization in Heartmate 3 Versus Heartmate II Left Ventricular Assist Device Recipients

  2021cites this paper
• Impact of Cardiopulmonary Bypass with Left Ventricular Inspection on Outcome after Implantation of Left Ventricular Assist Device.

  2021cites this paper
• Pathogen-reduced PRP blocks T-cell activation, induces Treg cells, and promotes TGF-β expression by cDCs and monocytes in mice.

  2020cites this paper
• HLA Allo-immunization Following Ventricular Assist Device Support Across the Age Spectrum.

  2019cites this paper
• Pathogen reduction with riboflavin and ultraviolet light induces a quasi‐apoptotic state in blood leukocytes

  2019cites this paper
• Mechanical Circulatory Support

  2019cites this paper
• Antibody-Mediated Rejection

  2017cites this paper
• Reduced MHC alloimmunization and partial tolerance protection with pathogen reduction of whole blood

  2017cites this paper
• Antibody-mediated rejection in the cardiac allograft: diagnosis, treatment and future considerations

  2017cites this paper
• Kunstherzen (Total Artificial Heart)

  2017cites this paper
• Influence of durable mechanical circulatory support and allosensitization on mortality after heart transplantation.

  2016cites this paper
• C1q‐binding anti‐HLA antibodies do not predict platelet transfusion failure in Trial to Reduce Alloimmunization to Platelets study participants

  2016cites this paper
• Reduced alloimmunization in mice following repeated transfusion with pathogen‐reduced platelets

  2016cites this paper
• Intraoperative and Postoperative Assessment and Management of Coagulopathy

  2016cites this paper
• Besonderheiten beim Einsatz von Kunstherzen

  2015cites this paper
• Utility of VerifyNow for Point-of-Care Identification of an Aspirin Effect Prior to Emergency Cardiac Surgery.

  2015cites this paper
• Factors associated with anti-human leukocyte antigen antibodies in patients supported with continuous-flow devices and effect on probability of transplant and post-transplant outcomes.

  2015cites this paper
• Ventricular assist devices in children

  2014cites this paper
• How do we manage cardiopulmonary bypass coagulopathy?

  2014cites this paper
• Antibody-mediated Rejection in Heart Transplantation

  2014cites this paper
• Human Leukocyte Antigen Sensitization in Pediatric Patients Exposed to Mechanical Circulatory Support

  2014cites this paper
• Immunological and hemostatic responses to ventricular assist device support

  2014cites this paper
• Quantification, Identification, and Relevance of Anti–Human Leukocyte Antigen Antibodies Formed in Association With the Berlin Heart Ventricular Assist Device in Children

  2013cites this paper
• make a difference? HLA sensitization in ventricular assist device recipients: Does type of device

  2013cites this paper
• Persistence of anti-human leukocyte antibodies in congenital heart disease late after surgery using allografts and whole blood.

  2013cites this paper
• Sensitization in Left Ventricular Assist Device Recipients Low-Dose Prophylactic Intravenous Immunoglobulin Does Not Prevent HLA

  2013cites this paper
• Alloimmunosensitization in left ventricular assist device recipients and impact on posttransplantation outcome.

  2012cites this paper
• Development, current status, and anesthetic management of the implanted artificial heart.

  2011cites this paper
• Heart transplantation in a highly sensitised patient.

  2011cites this paper
• How to deal with presensitized candidates for heart transplantation?

  2011cites this paper
• Heart transplantation in a highly sensitised patient Przeszczep serca u pacjenta ze znacznie zmodyfikowaną odpornością

  2011cites this paper
• Preclinical Biocompatibility Assessment of Pediatric Ventricular Assist Devices

  2010cites this paper
• Ventricular assist device-associated anti-human leukocyte antigen antibody sensitization in pediatric patients bridged to heart transplantation.

  2010cites this paper
• Model for End-Stage Liver Disease Score Predicts Left Ventricular Assist Device Operative Transfusion Requirements, Morbidity, and Mortality

  2010cites this paper
• Bridge to transplant experience: factors influencing survival to and after cardiac transplant.

  2010cites this paper
• The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation.

  2010cites this paper
• Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.

  2010cites this paper
• Platelet transfusions: the science behind safety, risks and appropriate applications.

  2010cites this paper
• Report from a consensus conference on the sensitized patient awaiting heart transplantation.

  2009cites this paper
• Bridge to Heart Transplantation with Left Ventricular Assist Device Versus Inotropic Agents in Status 1 Patients

  2009cites this paper
• Lack of significant de novo HLA allosensitization in ventricular assist device recipients transfused with leukoreduced, ABO identical blood products.

  2009cites this paper
• HLA sensitization in pediatric pre-transplant cardiac patients supported by mechanical assist devices: the utility of Luminex.

  2009cites this paper
• Management of allosensitized cardiac transplant candidates.

  2009cites this paper
• Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization.

  2009cites this paper
• Allosensitization in bridge to transplant Novacor left ventricular assist device patients: analysis of long-term outcomes with regard to acute rejection and chronic allograft vasculopathy.

  2008cites this paper
• New concepts of complement in allorecognition and graft rejection.

  2007cites this paper
• Treatment With Riboflavin and Ultraviolet Light Prevents Alloimmunization to Platelet Transfusions and Cardiac Transplants

  2007cites this paper
• Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions.

  2007cites this paper
• Imuninë sensitizacija po dirbtinës ðirdies prijungimo Immune sensitization after artificial heart support device implantation

  2007cites this paper
• Sensitization Following LVAD Implantation Using Leucodepleted Blood Is Not Due to HLA Antibodies

  2006cites this paper
• Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients.

  2006cites this paper
• Acute antibody-mediated rejection of cardiac transplants.

  2006cites this paper
• Is bridging to transplantation with a left ventricular assist device a risk factor for transplant coronary artery disease?

  2005cites this paper
• Management of patients with preformed reactive antibodies who are awaiting cardiac transplantation.

  2005cites this paper
• Impact of left ventricular assist device (LVAD)-mediated humoral sensitization on post-transplant outcomes.

  2005cites this paper
• The expanding role of ventricular assist devices in the management of end-stage heart failure

  2005cites this paper
• Relationship between bridging with ventricular assist device on rejection after heart transplantation.

  2005cites this paper
• Early and late rejection and HLA sensitization at the time of heart transplantation in patients bridged with left ventricular assist devices.

  2005cites this paper
• Blood transfusions decrease the incidence of acute rejection in cardiac allograft recipients.

  2005cites this paper
• Alloantibody and xenoantibody cross-reactivity in transplantation.

  2004cites this paper
• HLA sensitization in ventricular assist device recipients: does type of device make a difference?

  2004cites this paper
• Incidence and specificity of HLA antibodies in multitransfused patients with acquired aplastic anemia

  2004cites this paper
• Mechanical Circulatory Assistance As a Bridge to Transplantation

  2004cites this paper
• The role of bridge to transplantation: should LVAD patients be transplanted?

  2004cites this paper
• REACTIVE ANTIBODIES WHO ARE AWAITING

  2004cites this paper
• Sensitivity, Ventricular Assist Devices, and the Waiting Game in Heart Transplantation: What's New?

  2004cites this paper
• What Price Support? Ventricular Assist Device Induced Systemic Response

  2003cites this paper
• Allosensitization in heart transplantation: implications and management strategies

  2003cites this paper
• Immunologic sensitization in recipients of left ventricular assist devices.

  2003cites this paper
• Preformed anti-human leukocyte antigen antibodies jeopardize cardiac transplantation in patients with a left ventricular assist device.

  2002cites this paper
• Intravenous Pulse Administration of Cyclophosphamide Is an Effective and Safe Treatment for Sensitized Cardiac Allograft Recipients

  2002cites this paper
• HLA alloimmunization in patients requiring ventricular assist device support.

  2002cites this paper
• B-cell activation and allosensitization after left ventricular assist device implantation is due to T-cell activation and CD40 ligand expression.

  2002cites this paper
• Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation: effects on subsequent allograft rejection and survival.

  2001cites this paper
• Circulatory assist devices 2000: an update.

  2000cites this paper
• [Circulatory assistance while waiting for heart transplantation. Outcome of heart transplantation after mechanical circulatory assistance].

  2000cites this paper
• Six-year experience of caring for forty-four patients with a left ventricular assist device at home: safe, economical, necessary.

  2000cites this paper
• Immunobiology of left ventricular assist devices.

  2000cites this paper
• Quantitative changes in T-cell populations after left ventricular assist device implantation: relationship to T-cell apoptosis and soluble CD95.

  1999cites this paper
• Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients.

  1999cites this paper
• Measures to control blood activation during assisted circulation.

  1998cites this paper
• Detection of anti-HLA antibody by flow cytometry in patients with a left ventricular assist device is associated with early rejection following heart transplantation.

  1998cites this paper